Applied Therapeutics To Present Full 12-Month Clinical Results From The INSPIRE Phase 3 Trial Of Govorestat In A Late-Breaking Abstract Selected For Oral Presentation At The Peripheral Nerve Society 2025 Annual Meeting, Being Held May 17-20, 2025 In Edinburgh, Scotland